Cargando…

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

BACKGROUND: To retrospectively analyze whether primary tumor volume and primary nodal volume could be considered independent prognostic factors for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. METHODS: Three hundred sixty-three consecutive nasopharyngeal carcinoma (NP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Mei, Wang, Weidong, Fan, Zixuan, Fu, Binyu, Li, Jie, Zhang, Shichuan, Lang, Jinyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846569/ https://www.ncbi.nlm.nih.gov/pubmed/24007375 http://dx.doi.org/10.1186/1748-717X-8-208

Ejemplares similares

Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
por: Wang, Weidong, et al.
Publicado: (2014)

Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma
por: Feng, Mei, et al.
Publicado: (2018)

Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy
por: Xiao, WeiWei, et al.
Publicado: (2015)

Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma
por: Luo, Yangkun, et al.
Publicado: (2016)

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Liang, Shao-Bo, et al.
Publicado: (2017)

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
por: He, Yu-Xiang, et al.
Publicado: (2016)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy
por: Liao, Jun-Fang, et al.
Publicado: (2016)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

DW-MRI-Guided Dose Escalation Improves Local Control of Locally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
por: Huang, Yecai, et al.
Publicado: (2020)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
por: Zeng, Lei, et al.
Publicado: (2015)

Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
por: Zhang, Shichuan, et al.
Publicado: (2020)

The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
por: Ni, Weiqiong, et al.
Publicado: (2019)

Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2013)

Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy
por: Yang, Xiaojing, et al.
Publicado: (2020)

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Yeh, Shyh-An, et al.
Publicado: (2021)

Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensitymatched analysis
por: Chen, Yu-Pei, et al.
Publicado: (2016)

Standardized tumor volume: an independent prognostic factor in advanced nasopharyngeal carcinoma
por: Liu, Ting, et al.
Publicado: (2017)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)

Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Zhou, Guan-Qun, et al.
Publicado: (2016)

Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Tan, Wenyong, et al.
Publicado: (2013)

Local control and failure patterns after intensity modulated radiotherapy with reduced target volume delineation after induction chemotherapy for patients with T4 nasopharyngeal carcinoma
por: Kong, Fang-Fang, et al.
Publicado: (2021)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study
por: Luo, Yangkun, et al.
Publicado: (2016)

Pretreatment Low Serum Sodium as a Prognostic Factor for Patients with Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy
por: Lu, Jianchao, et al.
Publicado: (2022)

Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Li, Jia-xin, et al.
Publicado: (2014)

Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens
por: Zheng, Li, et al.
Publicado: (2018)

Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
por: Tang, Ling-Long, et al.
Publicado: (2014)

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control
por: Akbaba, Sati, et al.
Publicado: (2019)

The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2016)

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy
por: Son, Seok Hyun, et al.
Publicado: (2016)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
por: Chang, Hui, et al.
Publicado: (2018)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
por: Li, Qian, et al.
Publicado: (2021)

Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qhmr8c6ct5m87e1blgkb7tflke